Allergy Treatment Market

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. The rising importance for self-medication
3.5.1.2. Increase in incidence of food allergies across the globe
3.5.1.3. Increased investment by the manufacturers on the development of novel allergic treatments

3.5.2. Restraints

3.5.2.1. Rise in preference towards the use of biosimilars
3.5.2.2. Low awareness of allergy immunotherapy (AIT) among patients

3.5.3. Opportunity

3.5.3.1. Innovative developments in the field of immunotherapy

CHAPTER 4: ALLERGY TREATMENT MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Eye allergy

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Rhinitis

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Asthma

4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Skin Allergy

4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Food Allergies

4.6.1. Key trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Other Allergies

4.7.1. Key trends and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

CHAPTER 5: ALLERGY TREATMENT MARKET, BY TREATMENT

5.1. Overview

5.1.1. Market size and forecast

5.2. Anti-Allergy Drugs

5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Antihistamines

5.2.3.1. Market size and forecast

5.2.4. Corticosteroids

5.2.4.1. Market size and forecast

5.2.5. Decongestants

5.2.5.1. Market size and forecast

5.2.6. Other Drugs

5.2.6.1. Market size and forecast

5.3. Immunotherapy

5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.3. Subcutaneous Immunotherapy (SCIT)

5.3.3.1. Market size and forecast

5.3.4. Sun-Lingual Immunotherapy (SLIT)

5.3.4.1. Market size and forecast

CHAPTER 6: ALLERGY TREATMENT MARKET, BY DOSAGE FORM

6.1. Overview

6.1.1. Market size and forecast

6.2. Oral

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Inhalers

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Intranasal

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Others

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL

7.1. Overview

7.1.1. Market size and forecast

7.2. Retail pharmacies

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Hospital Pharmacies

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Online Retailers

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

7.5. Others

7.5.1. Market size and forecast
7.5.2. Market analysis, by country

CHAPTER 8: ALLERGY TREATMENT MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key trends and opportunities

8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. market size and forecast, by type
8.2.2.2. U.S. market size and forecast, by treatment
8.2.2.3. U.S. market size and forecast, by dosage form
8.2.2.4. U.S. market size and forecast, by distribution channel
8.2.2.5. Canada market size and forecast, by type
8.2.2.6. Canada market size and forecast, by treatment
8.2.2.7. Canada market size and forecast, by dosage form
8.2.2.8. Canada market size and forecast, by distribution channel
8.2.2.9. Mexico market size and forecast, by type
8.2.2.10. Mexico market size and forecast, by treatment
8.2.2.11. Mexico market size and forecast, by dosage form
8.2.2.12. Mexico market size and forecast, by distribution channel

8.2.3. North America market size and forecast, by type
8.2.4. North America market size and forecast, by treatment
8.2.5. North America market size and forecast, by dosage form
8.2.6. North America market size and forecast, by distribution channel

8.3. Europe

8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany market size and forecast, by type
8.3.2.2. Germany market size and forecast, by treatment
8.3.2.3. Germany market size and forecast, by dosage form
8.3.2.4. Germany market size and forecast, by distribution channel
8.3.2.5. UK market size and forecast, by type
8.3.2.6. UK market size and forecast, by treatment
8.3.2.7. UK market size and forecast, by dosage form
8.3.2.8. UK market size and forecast, by distribution channel
8.3.2.9. France market size and forecast, by type
8.3.2.10. France market size and forecast, by treatment
8.3.2.12. France market size and forecast, by dosage form
8.3.2.13. France market size and forecast, by distribution channel
8.3.2.14. Rest of Europe market size and forecast, by Type
8.3.2.15. Rest of Europe market size and forecast, by treatment
8.3.2.16. Rest of Europe market size and forecast, by dosage form
8.3.2.17. Rest of Europe market size and forecast, by distribution channel

8.3.3. Europe market size and forecast, by type
8.3.4. Europe market size and forecast, by treatment
8.3.5. Europe market size and forecast, by dosage form
8.3.6. Europe market size and forecast, by distribution channel

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan market size and forecast, by type
8.4.2.2. Japan market size and forecast, by treatment
8.4.2.3. Japan market size and forecast, by dosage form
8.4.2.4. Japan market size and forecast, by distribution channel
8.4.2.5. China market size and forecast, by type
8.4.2.6. China market size and forecast, by treatment
8.4.2.7. China market size and forecast, by dosage form
8.4.2.8. China market size and forecast, by distribution channel
8.4.2.9. India market size and forecast, by type
8.4.2.10. India market size and forecast, by treatment
8.4.2.11. India market size and forecast, by dosage form
8.4.2.12. India market size and forecast, by distribution channel
8.4.2.13. Australia market size and forecast, by type
8.4.2.14. Australia market size and forecast, by treatment
8.4.2.15. Australia market size and forecast, by dosage form
8.4.2.16. Australia market size and forecast, by distribution channel
8.4.2.17. South Korea market size and forecast, by type
8.4.2.18. South Korea market size and forecast, by treatment
8.4.2.19. South Korea market size and forecast, by dosage form
8.4.2.20. South Korea market size and forecast, by distribution channel
8.4.2.21. Rest of Asia-Pacific market size and forecast, by type
8.4.2.22. Rest of Asia-Pacific market size and forecast, by treatment
8.4.2.23. Rest of Asia-Pacific market size and forecast, by dosage form
8.4.2.24. Rest of Asia-Pacific market size and forecast, by distribution channel

8.4.3. Asia-Pacific market size and forecast, by type
8.4.4. Asia-Pacific market size and forecast, by treatment
8.4.5. Asia-Pacific market size and forecast, by dosage form
8.4.6. Asia-Pacific market size and forecast, by distribution channel

8.1. LAMEA

8.1.1. Key market trends and opportunities
8.1.2. LAMEA market size and forecast, by country

8.1.2.1. Brazil market size and forecast, by type
8.1.2.2. Brazil market size and forecast, by treatment
8.1.2.3. Brazil market size and forecast, by dosage form
8.1.2.4. Brazil market size and forecast, by distribution channel
8.1.2.5. South Africa market size and forecast, by type
8.1.2.6. South Africa market size and forecast, by treatment
8.1.2.7. South Africa market size and forecast, by dosage form
8.1.2.8. South Africa market size and forecast, by distribution channel
8.1.2.9. Saudi Arabia market size and forecast, by type
8.1.2.10. Saudi Arabia market size and forecast, by treatment
8.1.2.11. Saudi Arabia market size and forecast, by dosage form
8.1.2.12. Saudi Arabia market size and forecast, by distribution channel
8.1.2.13. Turkey market size and forecast, by type
8.1.2.14. Turkey market size and forecast, by treatment
8.1.2.15. Turkey market size and forecast, by dosage form
8.1.2.16. Turkey market size and forecast, by distribution channel
8.1.2.17. Rest of LAMEA market size and forecast, by type
8.1.2.18. Rest of LAMEA market size and forecast, by treatment
8.1.2.19. Rest of LAMEA market size and forecast, by dosage form
8.1.2.20. Rest of LAMEA market size and forecast, by distribution channel

8.1.3. LAMEA market size and forecast, by type
8.1.4. LAMEA market size and forecast, by treatment
8.1.5. LAMEA market size and forecast, by dosage form
8.1.6. LAMEA market size and forecast, by distribution channel

CHAPTER 9: COMPANY PROFILES

9.1. Merck KGaA (Allergopharma)

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments

9.2. GlaxoSmithKline plc

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance

9.3. F. Hoffmann-La Roche Ltd. (Genentech Inc.)

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. Johnson & Johnson

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. Allergy Therapeutics plc

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance

9.6. AALK-Abello A/S

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments

9.7. Sanofi SA

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. Stallergenes Greer plc

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. Allergan Plc.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance

9.10. Merck & Co. Inc.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 02. GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 03. GLOBAL RHINITIS ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL ASTHMA ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL SKIN ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 06. GLOBAL FOOD ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. GLOBAL OTHER ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. GLOBAL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 09. GLOBAL ALLERGY TREATMENT MARKET, FOR ANTI-ALLERGY DRUGS, BY REGION, 20172025 ($MILLION)
TABLE 10. GLOBAL IMMNUNOTHERAPY ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 12. ALLERGY TREATMENT MARKET, FOR ORAL DOSGE FORM, BY REGION, 20172025 ($MILLION)
TABLE 13. ALLERGY TREATMENT MARKET, FOR INHALERS, BY REGION, 20172025 ($MILLION)
TABLE 14. INTRANASAL MARKET, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHER DOSAGE FORMBY REGION, 20172025 ($MILLION)
TABLE 16. GLOBAL ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 17. GLOBAL ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACIES BY REGION, 20172025 ($MILLION)
TABLE 18. GLOBAL ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 20172025 ($MILLION)
TABLE 19. GLOBAL ALLERGY TREATMENT MARKET, FOR ONLINE RETAILERS, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHERS BY REGION, 20172025 ($MILLION)
TABLE 21. GLOBAL ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 22. NORTH AMERICA ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 23. U.S. ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 24. U.S. ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 25. U.S. ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 26. U.S. ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 27. CANADA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 28. CANADA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 29. CANADA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 30. CANADA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 31. MEXICO ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 32. MEXICO ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 33. MEXICO ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 34. MEXICO ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 37. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 38. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL 20172025 ($MILLION)
TABLE 39. EUROPE ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 40. GERMANY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 41. GERMANY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 42. GERMANY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 43. GERMANY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 44. UK ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 45. UK ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 46. UK ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 47. UK ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 48. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 49. FRANCE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 50. FRANCE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 51. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 52. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 53. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 54. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 55. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 56. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 57. EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 58. EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 59. EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 60. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 61. JAPAN ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 62. JAPAN ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 63. JAPAN ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 64. JAPAN ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 65. CHINA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 66. CHINA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 67. CHINA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 68. CHINA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 69. INDIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 70. INDIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 71. INDIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 72. INDIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 73. AUSTRALIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 74. AUSTRALIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 75. AUSTRALIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 76. AUSTRALIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 77. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 78. SOUTH KOREA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 79. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 80. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 85. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 86. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 87. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 88. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 89. LAMEA ALLERY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 90. BRAZIL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 91. BRAZIL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 92. BRAZIL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 93. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 94. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 95. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 96. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 97. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 98. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 99. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 100. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 101. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 102. TURKEY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 103. TURKEY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 104. TURKEY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 105. TURKEY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 106. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 107. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 108. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 109. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 110. LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 111. LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 112. LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 113. LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 114. MERCK: COMPANY SNAPSHOT
TABLE 115. MERCK: OPERATING SEGMENTS
TABLE 116. MERCK: PRODUCT PORTFOLIO
TABLE 117. GSK: COMPANY SNAPSHOT
TABLE 118. GSK: OPERATING SEGMENTS
TABLE 119. GSK: PRODUCT PORTFOLIO
TABLE 120. ROCHE: COMPANY SNAPSHOT
TABLE 121. ROCHE: OPERATING SEGMENTS
TABLE 122. ROCHE: PRODUCT PORTFOLIO
TABLE 123. J&J: COMPANY SNAPSHOT
TABLE 124. J&J: OPERATING SEGMENTS
TABLE 125. J & J: PRODUCT PORTFOLIO
TABLE 126. ALLERGY THERAPEUTICS: COMPANY SNAPSHOT
TABLE 127. ALLERGY THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 128. ALK: COMPANY SNAPSHOT
TABLE 129. ALK: OPERATING SEGMENTS
TABLE 130. ALK: PRODUCT PORTFOLIO
TABLE 131. SANOFI: COMPANY SNAPSHOT
TABLE 132. SANOFI: OPERATING SEGMENTS
TABLE 133. SANOFI: PRODUCT PORTFOLIO
TABLE 134. STALLERGENES: COMPANY SNAPSHOT
TABLE 135. STALLERGENES: OPERATING SEGMENTS
TABLE 136. STALLERGENES: PRODUCT PORTFOLIO
TABLE 137. ALLERGAN: COMPANY SNAPSHOT
TABLE 138. ALLERGAN: OPERATING SEGMENTS
TABLE 139. ALLERGAN: PRODUCT PORTFOLIO
TABLE 140. MERCK: COMPANY SNAPSHOT
TABLE 141. MERCK: OPERATING SEGMENTS
TABLE 142. MERK: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. ALLERGY TREATMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 06. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTION
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS, 2017
FIGURE 12. GLOBAL ALLERGY TREATMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF RHINITIS ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ASTHMA ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SKIN ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FOOD ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF OTHER ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ANTI-ALERGY DRUGS BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. GLOBAL ALLERGY TREATMENT MARKET FOR ANTIHISTAMINES, 20172025 ($MILLION)
FIGURE 21. GLOBAL ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, 20172025 ($MILLION)
FIGURE 22. GLOBAL ALLERGY TREATMENT MARKET FOR DECONGESTANTS, 20172025 ($MILLION)
FIGURE 23. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR IMMUOTHERAPY BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 26. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ORAL DOSAGE FORM, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INHALER, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INTRANASAL, BY COUNTRY, 2017 & 2025 (%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR ONLINE RETAILERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 35. MERCK: REVENUE, 20152017 ($MILLION)
FIGURE 36. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. GSK: NET SALES, 20152017 ($MILLION)
FIGURE 39. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 42. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. J&J: NET SALES, 20152017 ($MILLION)
FIGURE 44. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. ALLERGY THERAPEUTICS: NET SALES, 20152017 ($MILLION)
FIGURE 47. ALK: NET SALES, 20152017 ($MILLION)
FIGURE 48. ALK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. ALK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 50. SANOFI: NET SALES, 20152017 ($MILLION)
FIGURE 51. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 53. STALLERGENES: REVENUE, 20152017 ($MILLION)
FIGURE 54. STALLERGENES: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 55. STALLERGENES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 56. ALLERGAN: NET SALES, 20152017 ($MILLION)
FIGURE 57. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 58. MERCK: NET SALES, 20152017 ($MILLION)
FIGURE 59. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 60. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)